Stay updated on Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:53:45.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:20:48.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the usual study details with an access-block message.
    Difference
    19%
    Check dated 2026-09-20T01:09:50.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6 in place of v3.6.5, indicating a maintenance update rather than changes to the trial information.
    Difference
    0.1%
    Check dated 2026-08-29T19:46:08.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.4 to v3.6.5, representing an updated version of the study page.
    Difference
    0.1%
    Check dated 2026-08-08T09:40:30.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.3 to v3.6.4, signaling a new version of the page or its backend patch. This change reflects an internal update rather than a substantive modification to the displayed information.
    Difference
    0.1%
    Check dated 2026-07-25T06:24:16.000Z thumbnail image

Stay in the know with updates to Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.